Validation of the Hematopoietic Cell Transplantation-Specific Comorbidity Index in a retrospective cohort of children and adolescents who received an allogeneic transplantation in Argentina | Zendy

Carlos M. Figueroa Turienzo | Zendy; Carolina Cernadas | Zendy; M.F. Roizen | Zendy; Silvia Pizzi | Zendy; Raquel Staciuk | Zendy

Open Access

Validation of the Hematopoietic Cell Transplantation-Specific Comorbidity Index in a retrospective cohort of children and adolescents who received an allogeneic transplantation in Argentina

Author(s) -

Carlos M. Figueroa Turienzo,

Carolina Cernadas,

M.F. Roizen,

Silvia Pizzi,

Raquel Staciuk

Publication year - 2016

Publication title -

archivos argentinos de pediatria

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.236

H-Index - 19

eISSN - 1668-3501

pISSN - 0325-0075

DOI - 10.5546/aap.2016.eng.337

Subject(s) - medicine , retrospective cohort study , transplantation , comorbidity , hematopoietic stem cell transplantation , cohort , hematopoietic cell , cohort study , haematopoiesis , stem cell , biology , genetics

Hematopoietic cell transplantationis a therapy with a risk of transplant-related mortality (TRM), which may vary depending on prior comorbidities. The Hematopoietic Cell Transplantation-Specific Comorbidity Index (HCT-CI) is an instrument developed to measure this risk. There are very few reports on its use in pediatrics. The objective of this study was to validate the HCT-CI in a pediatric cohort of allogeneic hematopoietic-cell transplantation recipients in Argentina.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research